Olema Pharmaceuticals (OLMA) Interest Coverage Ratio (2020)

Olema Pharmaceuticals (OLMA) has reported Interest Coverage Ratio for 7 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 97.61% year-over-year to 0.63; the TTM figure through Mar 2026 stood at 2.2 (up 97.97% YoY), while the FY2025 annual figure was 0.76, up 95.99% from the prior year.
• Interest Coverage Ratio climbed to 0.63 in Q1 2026 per OLMA's latest filing, from 165.84 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.43 in Q3 2023 and bottomed at 165.84 in Q4 2025.
• Historically, Interest Coverage Ratio has averaged 42.73 across 5 years, with a median of 9.47 in 2022.
• Annual changes were most pronounced in 2025 — Interest Coverage Ratio sank 17189.25% — and 2026, when it surged 97.61%.
• Olema Pharmaceuticals' Interest Coverage Ratio stood at 84.27 in 2022, then sank by 37.24% to 115.65 in 2023, then decreased by 3.9% to 120.16 in 2024, then plunged by 38.02% to 165.84 in 2025, then jumped by 99.62% to 0.63 in 2026.
• Business Quant data shows OLMA's Interest Coverage Ratio at 0.63 in Q1 2026, 165.84 in Q4 2025, and 147.04 in Q3 2025.